Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001571049-14-001063
Filing Date
2014-04-07
Accepted
2014-04-04 19:53:36
Documents
1

Document Format Files

Seq Description Document Type Size
1 FINAL PROSPECTUS SUPPLEMENT t1400599_424b5.htm 424B5 585047
  Complete submission text file 0001571049-14-001063.txt   586149
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-187801 | Film No.: 14747140
SIC: 2834 Pharmaceutical Preparations